Kaiser Corporation files for BSE in-principle approval to absorb Emazing Deals

Scheme filed with the NCLTStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.7%Reaction day

₹6.20

prior close

₹6.34

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-4.4% vs market

Trading & Distributors peers, median of 137sector+0.0%-3.7% vs sector

On the reaction day the stock moved 4.4 pts less than Nifty Microcap 250 and 3.7 pts less than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.9

10m

-2.8

15m

-3.2

30m

-5.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.7+0.7-4.4+0.0-3.7

Next day

-4.0+1.1-5.1-0.2-3.8

-4.0+1.6-5.7+0.0-4.0

-3.2+1.5-4.7-1.4-1.8

-4.8+1.3-6.1-1.6-3.3

-5.3+1.4-6.7-1.2-4.2

-6.6-2.1-4.5-2.7-3.9

15d

-4.0-0.9-3.1-3.8-0.3

-6.5-1.4-5.0-4.9-1.6

-15.5-5.5-10.0-6.7-8.8

—————

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 137Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kaiser Corporation has applied to BSE on September 2, 2026 seeking in-principle approval for the Scheme of Amalgamation to absorb Emazing Deals Limited into itself. The application was filed under SEBI LODR Regulations 30 and 37 as part of the formal merger process. Once exchange clearance is obtained, the scheme will be taken to the NCLT for final sanction. No swap ratio or valuation details have been disclosed in this intimation.

Likely market impact

If approved, Emazing Deals will merge into Kaiser. Watch for swap ratio and NCLT approval timelines for stock action.